We are live on ! Find out more
SP

Sarasin & Partners Portfolio holdings

AUM $8.54B
1-Year Est. Return 9.6%
This Fund
S&P 500
This Quarter Est. Return
+5.54%
1 Year Est. Return
+9.6%
3 Year Est. Return
+77.95%
5 Year Est. Return
+86.04%
10 Year Est. Return
+393.05%
AUM
$7.15B
AUM Growth
+$134M
Cap. Flow
-$171M
Cap. Flow %
-2.39%
Top 10 Hldgs %
39.4%
Holding
139
New
7
Increased
31
Reduced
89
Closed
4

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$234M
2
VLO icon
Valero Energy
VLO
+$81.7M
3
TIF
Tiffany & Co.
TIF
+$53M
4
CXW icon
CoreCivic
CXW
+$42M
5
COST icon
Costco
COST
+$28.6M

Sector Composition

Rank Sector Weight
1 Financials 14.77%
2 Consumer Discretionary 13.82%
3 Communication Services 11.81%
4 Industrials 11.19%
5 Materials 10.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMR icon
26
Emerson Electric
EMR
$83.8B
$108M 1.51%
1,625,194
+204,693
+14% +$13.8M
ISRG icon
27
Intuitive Surgical
ISRG
$126B
$103M 1.45%
2,260,638
+276,012
+14% +$12.2M
TIF
28
DELISTED
Tiffany & Co.
TIF
$103M 1.44%
1,028,659
-571,495
-36% -$53M
CP icon
29
Canadian Pacific Kansas City
CP
$78.3B
$97.6M 1.37%
2,694,040
+46,850
+2% +$1.54M
DD
30
DELISTED
Du Pont De Nemours E I
DD
$91.3M 1.28%
1,469,533
-17,294
-1% -$1.11M
SBS icon
31
Sabesp
SBS
$19.3B
$83M 1.16%
39,915,630
+38,640,721
+3,031% +$74.1M
INFA
32
DELISTED
INFORMATICA CORP
INFA
$80.1M 1.12%
2,246,951
+187,527
+9% +$6.9M
ACWI icon
33
iShares MSCI ACWI ETF
ACWI
$32.7B
$76.9M 1.08%
1,275,903
+64,926
+5% +$3.85M
DIS icon
34
Walt Disney
DIS
$167B
$72.9M 1.02%
850,287
-60,399
-7% -$4.93M
OPLN
35
Openlane
OPLN
$4.2B
$69.9M 0.98%
5,797,370
+97,807
+2% +$1.13M
SQM icon
36
Sociedad Química y Minera de Chile
SQM
$19.1B
$69.5M 0.97%
2,435,922
-86,496
-3% -$2.57M
TTM
37
DELISTED
Tata Motors Limited
TTM
$59.6M 0.83%
+1,525,538
New +$58.6M
CUK
38
DELISTED
Carnival PLC
CUK
$58.3M 0.82%
1,544,585
+178,108
+13% +$7.03M
PFE icon
39
Pfizer
PFE
$143B
$55.7M 0.78%
1,977,668
-8,207,451
-81% -$234M
GE icon
40
GE Aerospace
GE
$373B
$52M 0.73%
412,597
+18,153
+5% +$2.31M
GRMN
41
Garmin
GRMN
$56.9B
$51.6M 0.72%
846,912
+16,355
+2% +$940K
CNK icon
42
Cinemark Holdings
CNK
$4.14B
$49.9M 0.7%
+1,412,047
New +$43.2M
VFC icon
43
VF Corp
VFC
$5.68B
$40M 0.56%
674,307
+68,257
+11% +$3.97M
VLO icon
44
Valero Energy
VLO
$91.1B
$37.8M 0.53%
753,509
-1,481,060
-66% -$81.7M
CTAS icon
45
Cintas
CTAS
$82.4B
$35.9M 0.5%
2,257,880
+901,600
+66% +$13.6M
MO icon
46
Altria Group
MO
$116B
$35.8M 0.5%
854,569
-21,898
-2% -$881K
MMM icon
47
3M
MMM
$90.8B
$35.8M 0.5%
298,879
+1,190
+0.4% +$140K
SLB icon
48
SLB Ltd
SLB
$73B
$33.8M 0.47%
286,401
-19,412
-6% -$2M
SPG icon
49
Simon Property Group
SPG
$75.2B
$32.2M 0.45%
193,398
-29,559
-13% -$4.83M
LEG icon
50
Leggett & Platt
LEG
$1.36B
$28.6M 0.4%
835,499
-180,599
-18% -$6.02M

Similar funds

Sarasin & Partners's Q2 2014 Portfolio in Review

As of Q2 2014, Sarasin & Partners held 139 positions worth $7.15B, up 1.9% from $7.01B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Sarasin & Partners's Q2 2014 filing shows 7 new, 31 increased, 89 reduced and 4 closed positions. Its largest new stake was Tata Motors Limited: 1,525,538 shares worth $59.6M. The largest sale was Pfizer, an estimated $234M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Sarasin & Partners's largest Q2 2014 buy was Tata Motors Limited: 1,525,538 shares worth $59.6M.
  • Sarasin & Partners added most to Anadarko Petroleum in Q2 2014, an estimated $111M increase.
  • Sarasin & Partners's biggest Q2 2014 reduction was Pfizer, cutting an estimated $234M.
  • Sarasin & Partners fully exited CATAMARAN CORP COM STK (CDA) in Q2 2014, selling an estimated $4.94M.
  • Sarasin & Partners's ten largest holdings make up 39% of its $7.15B portfolio in Q2 2014.
  • Sarasin & Partners opened 7 new positions and closed 4 in Q2 2014.
  • Sarasin & Partners's portfolio value rose 1.9% quarter-over-quarter to $7.15B.

Based on Sarasin & Partners's 13F filing for Q2 2014, filed 14 Jul 2014.